Abstract
Nanocarriers Based Oral Insulin Delivery Successful oral administration of protein drugs remains an obscure challenge. In this context, oral insulin delivery has always been a significant challenge for pharmaceutical researchers and considerable efforts are being made to deliver insulin orally. Oral insulin therapy seems to have progressed with nanotechnology research, allowing for several types of encapsulations to bypass the gastric acidic environment. Nanoparticles protect insulin against degradation and facilitate the uptake of insulin (associated or not associated to the nanoparticles) through a paracellular or a transcellular pathway. In oral insulin, the mechanism involves various nanoparticle encasings bound to insulin delivery. Continuous comparisons of in vitro and in vivo studies are essential to develop oral insulin delivery systems in near future.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Nanomaterials & Molecular Nanotechnology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
